Is this you? Create Your Porfile
Avatar

H-M. Chang

University of Ulsan

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where H-M. Chang is active.

Explore More

Publication

Featured researches published by H-M. Chang.

Annals of Oncology | 2002

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer

Tae Won Kim; Yoon-Koo Kang; J. H. Ahn; H-M. Chang; J. H. Yook; Seong Taek Oh; Byung Soo Kim; J. Lee

Annals of Oncology | 2016

Oral rivaroxaban versus subcutaneous low molecular weight heparin treatment for venous thromboembolism in patients with upper gastrointestinal, hepatobiliary and pancreatic cancer

S. Seo; M-H Ryu; Y-K. Kang; K-P. Kim; H-M. Chang; B-Y Ryoo; S-B Kim; J-L. Lee; Sook Ryun Park

Annals of Oncology | 2018

766PPrognostic factors in patients with advanced biliary tract cancer (BTC) who showed durable disease control with first-line gemcitabine plus cisplatin (GemCis)

J Hyung; Cheol-In Yoo; K-P. Kim; B J Kim; J H Jeong; H-M. Chang; B-Y Ryoo

Annals of Oncology | 2018

725PEfficacy and safety of nab-paclitaxel plus gemcitabine (AG) vs. FOLFIRINOX (FFX) as first line chemotherapy for metastatic pancreatic cancer (mPC): Retrospective analysis

Kyoo Hyung Lee; I Hwang; J Kang; Cheol-In Yoo; K-P. Kim; J H Jeong; H-M. Chang; B-Y Ryoo

Annals of Oncology | 2018

729PPrognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG)

I Hwang; Jung Hun Kang; Cheol-In Yoo; J H Jeong; K-P. Kim; H-M. Chang; B-Y Ryoo

Annals of Oncology | 2017

719PPrognostic impact of hepatitis B virus (HBV) infection in advanced intrahepatic cholangiocarcinoma (iCCA) patients (pts) treated with first-line gemcitabine plus cisplatin (GEMCIS)

E.J. Kim; H. Cho; Cheol-In Yoo; K-P. Kim; H-M. Chang; B-Y Ryoo

Annals of Oncology | 2017

717PPrognostic implication of inflammation-based prognostic scores in patients with intrahepatic cholangiocarcinoma (iCCA) treated with first-line Gemcitabine plus Cisplatin (GEMCIS)

H. Cho; Cheol-In Yoo; K-P. Kim; H-M. Chang; B-Y Ryoo

Annals of Oncology | 2017

718PPhase 2 study of triplet chemotherapy with oxaliplatin, irinotecan and S-1 (OIS) as first-line treatment in patients with advanced biliary tract cancer (BTC)

Cheol-In Yoo; B. Han; K-P. Kim; H.S. Kim; Jin Hee Kim; H-M. Chang; B-Y Ryoo; D.Y. Zang

Annals of Oncology | 2016

261P Efficacy of chemotherapy in patients with unresectable or metastatic pancreatic acinar cell carcinoma: Potentially improved efficacy with oxaliplatin-containing regimen

J. Cheon; Cheol-In Yoo; Beom Kyung Kim; K-P. Kim; J-L. Lee; T.W. Kim; B-Y Ryoo; H-M. Chang

Annals of Oncology | 2016

Efficacy of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma

Jung Hun Kang; K-P. Kim; Cheol-In Yoo; J-L. Lee; B-Y Ryoo; H-M. Chang; S.S. Lee; D.H. Park; T.J. Song; Dong Wan Seo; S.-K. Lee; M-H. Kim; D.W. Hwang; K.B. Song; Jung-Shin Lee; Seung Cheol Kim

Explore More

Collaboration

Dive into the H-M. Chang's collaboration.

Top Co-Authors
Avatar

B-Y Ryoo

University of Ulsan

View shared research outputs
Top Co-Authors
Avatar

K-P. Kim

University of Ulsan

View shared research outputs
Top Co-Authors
Avatar

Cheol-In Yoo

University of Ulsan

View shared research outputs
Top Co-Authors
Avatar

J H Jeong

University of Ulsan

View shared research outputs
Top Co-Authors
Avatar

J-L. Lee

Seoul National University Hospital

View shared research outputs
Top Co-Authors
Avatar

H. Cho

University of Ulsan

View shared research outputs
Top Co-Authors
Avatar

I Hwang

University of Ulsan

View shared research outputs
Top Co-Authors
Avatar

Jung Hun Kang

Sungkyunkwan University

View shared research outputs
Top Co-Authors
Avatar

Seung Cheol Kim

Ewha Womans University

View shared research outputs
Top Co-Authors
Avatar

B J Kim

University of Ulsan

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge